Invention Grant
- Patent Title: Compositions and methods for treating IgE-mediated disorders
-
Application No.: US13860500Application Date: 2013-04-10
-
Publication No.: US09617348B2Publication Date: 2017-04-11
- Inventor: John R. Desjarlais , Seung Y. Chu , Holly M. Horton , Matthew J. Bernett
- Applicant: Xencor, Inc.
- Applicant Address: US CA Monrovia
- Assignee: Xencor, Inc.
- Current Assignee: Xencor, Inc.
- Current Assignee Address: US CA Monrovia
- Agency: Morgan, Lewis & Bockius, LLP
- Agent Robin M. Silva; Louis T. Nguyen
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/42 ; C07K16/46
Abstract:
The present invention relates to immunoglobulins that bind IgE and FcγRIIb with high affinity, said compositions being capable of inhibiting cells that express membrane-anchored IgE. Such compositions are useful for treating IgE-mediated disorders, including allergies and asthma.
Public/Granted literature
- US20130203967A1 NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS Public/Granted day:2013-08-08
Information query
